The first solid-phase synthesis of a peptide-Tethered platinum(II) complex

Angewandte Chemie - International Edition

Volumn 39, Issue 17, 2000, Pages 3096-3099

  Robillard, Marc S ^a   Valentijn, A Rob P M ^a   Meeuwenoord, Nico J ^a   Van Der Marel, Gijs A ^a   Van Boom, Jacques H ^a   Reedijk, Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Antitumor agents; Cisplatin; Peptides; Platinum; Solid phase synthesis

Indexed keywords

CARBOPLATIN; CISPLATIN; PEPTIDE DERIVATIVE; PLATINUM DERIVATIVE; TRIMERIC ARGININE CONTAINING PEPTIDE DICHLOROPLATINUM COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; DNA ADDUCT; NUCLEAR OVERHAUSER EFFECT; PROTEIN DNA INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE EXTRACTION; SYNTHESIS;

EID: 0034283390     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-3773(20000901)39:17<3096::AID-ANIE3096>3.0.CO;2-D     Document Type: Article

References (28)

1. L. R. Kelland, Crit. Rev. Oncol. Hematol. 1993, 15, 191-219.
2. For example: a) P. Mailliet, E. Segal-Bendirdjian, J. Kozelka, M. Barreau, B. Baudoin, M.-C. Bissery, S. Gontier, A. Laoui, F. Lavelle, J. B. Le Pecq, J.-C. Chottard, Anti-Cancer Drug Des. 1995, 10, 51-73; b) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223; c) Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, P. G. Wang, Angew. Chem. 1999, 111, 1882-1884; Angew. Chem. Int. Ed. 1999, 38, 1768-1769, and references therein; d) J. Reedijk, Chem. Rev. 1999, 99, 2499- 2510.
3. For example: a) P. Mailliet, E. Segal-Bendirdjian, J. Kozelka, M. Barreau, B. Baudoin, M.-C. Bissery, S. Gontier, A. Laoui, F. Lavelle, J. B. Le Pecq, J.-C. Chottard, Anti-Cancer Drug Des. 1995, 10, 51-73; b) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223; c) Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, P. G. Wang, Angew. Chem. 1999, 111, 1882-1884; Angew. Chem. Int. Ed. 1999, 38, 1768-1769, and references therein; d) J. Reedijk, Chem. Rev. 1999, 99, 2499- 2510.
4. For example: a) P. Mailliet, E. Segal-Bendirdjian, J. Kozelka, M. Barreau, B. Baudoin, M.-C. Bissery, S. Gontier, A. Laoui, F. Lavelle, J. B. Le Pecq, J.-C. Chottard, Anti-Cancer Drug Des. 1995, 10, 51-73; b) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223; c) Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, P. G. Wang, Angew. Chem. 1999, 111, 1882-1884; Angew. Chem. Int. Ed. 1999, 38, 1768-1769, and references therein; d) J. Reedijk, Chem. Rev. 1999, 99, 2499- 2510.
5. For example: a) P. Mailliet, E. Segal-Bendirdjian, J. Kozelka, M. Barreau, B. Baudoin, M.-C. Bissery, S. Gontier, A. Laoui, F. Lavelle, J. B. Le Pecq, J.-C. Chottard, Anti-Cancer Drug Des. 1995, 10, 51-73; b) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223; c) Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, P. G. Wang, Angew. Chem. 1999, 111, 1882-1884; Angew. Chem. Int. Ed. 1999, 38, 1768-1769, and references therein; d) J. Reedijk, Chem. Rev. 1999, 99, 2499- 2510.
6. For example: a) P. Mailliet, E. Segal-Bendirdjian, J. Kozelka, M. Barreau, B. Baudoin, M.-C. Bissery, S. Gontier, A. Laoui, F. Lavelle, J. B. Le Pecq, J.-C. Chottard, Anti-Cancer Drug Des. 1995, 10, 51-73; b) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223; c) Y. Chen, M. J. Heeg, P. G. Braunschweiger, W. Xie, P. G. Wang, Angew. Chem. 1999, 111, 1882-1884; Angew. Chem. Int. Ed. 1999, 38, 1768-1769, and references therein; d) J. Reedijk, Chem. Rev. 1999, 99, 2499-2510.
7. a) R. Arya, J. Gariépy, Bioconjugate Chem. 1991, 2, 323-326, and references therein;
8. b) N. Y. Sardesai, S. C. Lin, K. Zimmermann, J. K. Barton, Bioconjugate Chem. 1995, 6, 302-312, and references therein;
9. e) M. P. Fitzsimons, J. K. Barton, J. Am. Chem. Soc. 1997, 119, 3379-3380;
10. d) M. F. Giblin, S. S. Jurisson, T. P. Quinn, Bioconjugate Chem. 1997, 8, 347-353;
11. e) R. H. Terbrueggen, T. W. Johann, J. K. Barton, Inorg. Chem. 1998, 37, 6874-6883, and references therein;
12. f) D. M. Herman, E. E. Baird, P. B. Dervan, J. Am. Chem. Soc. 1998, 120, 1382-1391;
13. g) C. A. Hastings, J. K. Barton, Biochemistry 1999, 38, 10042-10051;
14. h) K. S. Schmidt, D. V. Filippov, N. J. Meeuwenoord, G. A. van der Marel, J. H. van Boom, B. Lippert, J. Reedijk, Angew. Chem. 2000, 39, 383-385; Angew. Chem. Int. Ed. 2000, 39, 375-377.
15. h) K. S. Schmidt, D. V. Filippov, N. J. Meeuwenoord, G. A. van der Marel, J. H. van Boom, B. Lippert, J. Reedijk, Angew. Chem. 2000, 39, 383-385; Angew. Chem. Int. Ed. 2000, 39, 375-377.
16. M. Lee, J. E. Simpson, Jr., A. J. Burns, S. Kupchinsky, N. Brooks, J. A. Hartley, L. R. Kelland, Mat. Chem. Res. 1996, 6, 365-371.
17. a) J. Reedijk, Chem. Commun. 1996, 801-806;
18. b) Z. Guo, P. J. Sadler, Angew. Chem. 1999, 111, 1610-1630; Angew. Chem. Int. Ed. 1999, 38, 1512-1531;
19. b) Z. Guo, P. J. Sadler, Angew. Chem. 1999, 111, 1610-1630; Angew. Chem. Int. Ed. 1999, 38, 1512-1531;
20. c) E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2451-2466.
21. a) K. E. Sandman, P. Fuhrmann, S. J. Lippard, J. Biol. Inorg. Chem. 1998, 3, 74-80;
22. b) C. J. Ziegler, K.E. Sandman, C. H. Liang, S. J. Lippard, J. Biol. Inorg. Chem. 1999, 4, 402-411;
23. c) J. R. Appel, J. Johnson, V.L. Narayanan, R. A. Houghten, Mol. Diversity 1999, 4, 91-102.
24. J. Luo, T. C. Bruice, J. Am. Chem. Soc. 1997, 119, 6643-6701.
25. Recently, an attempt to prepare a 2,2′-bipyridine -dichloroplatinum complex by solid-phase synthesis was reported: S. Tadesse, A. Bhandari, M. A. Gallop, J. Comb. Chem. 1999, 1, 184-187.
26. E. Atherton, R. C. Sheppard, Solid Phase Peptide Synthesis: A Practical Approach, IRL, Oxford, UK, 1989, pp. 87-160.
27. S.A. Thomson, J. A. Josey, R. Cadilla, M. D. Gaul, C. F. Hassman, M. J. Luzzio, A. J. Pipe, K. L. Reed, D. J. Ricca, R. W. Wiethe, S. A. Noble. Tetrahedron 1995, 51, 6179-6194.
28. 13C NMR spectroscopy. ESI mass spectrometry, and capillary electrophoresis.